Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Lutathera

(LOO-tuh-THAYR-uh)
A radioactive drug used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors that are somatostatin receptor positive. It is also being studied in the treatment of other types of cancer. Lutathera binds to a protein called somatostatin receptor, which is found on some neuroendocrine tumor cells. Lutathera builds up in these cells and gives off radiation that may kill them. It is a type of radioconjugate and a type of somatostatin analog. Also called lutetium Lu 177-dotatate.
More Information
Search NCI's Dictionary of Cancer Terms